This study published in a highly respected medical journal highlights a major obstacle to bringing patients new treatments – not enough patients participating in clinical trials to provide the U.S. Food and Drug Administration with the data they require to approve new drugs. In a presentation at a recent Lupus Research Institute patient research conference, Dr. Richard Furie, Chief, Division of Rheumatology at North Shore LIK Health System, noted that there are not enough lupus patients for the number of trials needed to test all the potential new treatments. “Just for studies underway in New York alone, we need 10,000 patients.” And he noted that less than 5 percent of lupus patients currently participate. As Dr. Furie points out in his talk, there are many types of trials that patients as well as their family can be part of that can help advance lupus research. Learn more at LupusTrials.org.
April 2, 2014